Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    20978260 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel;   Drug: Ticagrelor
2 Completed Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
Condition: STEMI
Interventions: Genetic: Point-of-Care Genetic Testing;   Drug: Prasugrel
3 Completed Genotyping Influences Outcome of Coronary Artery Stenting
Conditions: Myocardial Ischemia;   CLOPIDOGREL, POOR METABOLISM of (Disorder)
Intervention: Drug: Clopidogrel
4 Unknown  Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment
Conditions: Myocardial Infarction;   STEMI
Intervention: Genetic: CYP2C19 genotyping

Study has passed its completion date and status has not been verified in more than two years.